| Literature DB >> 34707420 |
Maha Ali Al Mohaya1, Mansour M Almaziad2, Khalid A Al-Hamad3, Mohammad Mustafa4.
Abstract
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic necessitated widespread changes in delivery of dental care. Telemedicine utilization increased overnight during this pandemic because of its ability to enhance access to oral healthcare, easily link to remote area, time management, low cost, etc. We aimed to identify the utilization of telemedicine among oral medicine practitioners in Saudi Arabia during COVID-19 pandemic and identify future impacts, potential challenges and barriers hindering the implementation of telemedicine.Entities:
Keywords: COVID-19; awareness; barriers; oral medicine; telemedicine
Year: 2021 PMID: 34707420 PMCID: PMC8544785 DOI: 10.2147/RMHP.S325777
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Demographic and Professional Characteristics of Participants (N = 75)
| Characteristics | Number | Percentage |
|---|---|---|
| Gender | ||
| Female | 39 | 52.0 |
| Male | 36 | 48.0 |
| Nationality | ||
| Non-Saudi | 22 | 29.3 |
| Saudi | 53 | 70.7 |
| Age group | ||
| >55 | 3 | 4.00 |
| 25–35 | 36 | 48.0 |
| 36–45 | 24 | 32.00 |
| 46–55 | 12 | 16.0 |
| Professional level | ||
| Consultant | 34 | 45.3 |
| MSc/ PhD student | 2 | 2.67 |
| Resident | 18 | 24.0 |
| Specialist | 21 | 28.0 |
| Experience in oral medicine specialty (year) | ||
| >15 | 17 | 22.7 |
| 1–5 | 32 | 42.7 |
| 11–15 | 8 | 10.7 |
| 6–10 | 18 | 24.0 |
| To which health sector respondents belong to | ||
| Government hospital/clinic | 24 | 32.0 |
| Governmental university | 43 | 57.3 |
| Private hospital/clinic | 6 | 8.00 |
| Private university | 2 | 2.67 |
| The location of respondent’s practice? | ||
| Major city | 62 | 82.7 |
| Remote area | 1 | 1.33 |
| Town | 12 | 16.00 |
Abbreviation: N, number of participants.
Perceptions About the Usefulness of Telemedicine in Improving Dental Practice (N = 75)
| Characteristics | Frequency | Percentage | |
|---|---|---|---|
| Was the clinic deferred due to the COVID-19 pandemic? (% yes) | 70 | 93.3 | |
| How the respondents managed patients during COVID-19 pandemic? | |||
| Patient rebooking | 35 | 46.7 | |
| Attending urgent cases only | 28 | 37.3 | |
| Communicating through telemedicine | 41 | 54.7 | |
| Are you familiar with the use of telemedicine? (Yes) | 49 | 65.3 | |
| Does respondents practice setup support the use of telemedicine? | |||
| I do not know | 24 | 32.0 | |
| No | 30 | 40.0 | |
| Yes | 21 | 28.0 | |
| Have ever utilized any form of telemedicine before the COVID-19 pandemic? (% yes) | 35 | 46.7 | |
| Please specify the reasons for telemedicine use in practice before COVID-19 pandemic? | |||
| Consultation | 38 | 50.7 | |
| Clinical discussion with colleagues | 33 | 44.0 | |
| Scheduled follow-up | 17 | 22.7 | |
| Diagnose new cases | 11 | 14.7 | |
| Medication refill | 15 | 20.0 | |
| Teaching | 21 | 28.0 | |
| Which media do respondents prefer to use when communicate through telemedicine? | |||
| Hospital devices | 12 | 16.0 | |
| Personal computer | 17 | 22.7 | |
| Personal smartphone | 44 | 58.7 | |
| Personal tablet | 2 | 2.67 | |
| Have you been in communication with patients via telemedicine during the COVID-19 pandemic? (% yes) | 43 | 57.3 | |
| Which system/application were you using most to communicate with your patients? | |||
| Phone call | 30 | 40.0 | |
| 47 | 62.7 | ||
| 4 | 5.33 | ||
| Virtual videoconferencing | 5 | 6.67 | |
| What were the reasons for telemedicine use during the outbreak of COVID-19 pandemic? | |||
| Consultation | 54 | 72.0 | |
| Scheduled follow-up | 17 | 22.7 | |
| Diagnose new cases | 30 | 40.0 | |
| Medication refill | 20 | 26.7 | |
| Clinical discussion with colleague | 35 | 46.7 | |
| Teaching | 33 | 44.0 | |
| Have respondents ever experienced any cyber risk while using telemedicine in practice? (% yes) | 2 | 2.67 | |
| Was it convenient to use telemedicine?: | |||
| No | 8 | 10.7 | |
| Occasionally | 36 | 48.0 | |
| Yes | 31 | 41.3 | |
| The reasons for inconvenience | |||
| Not familiar with the technology | 3 | 4.00 | |
| Poor internet Connection | 3 | 4.00 | |
| Poor image quality | 16 | 21.3 | |
| Time consuming | 4 | 5.33 | |
| Patient dissatisfaction | 5 | 6.67 | |
| No proper set up | 4 | 5.33 | |
| Overall, how satisfied were the patients with the telemedicine services? | |||
| Dissatisfied | 4 | 5.33 | |
| I do not know | 37 | 49.3 | |
| Satisfied | 34 | 45.3 | |
Abbreviation: N, number of participants.
Comparison Between the Levels of Experience for Future Implications of Telemedicine
| Characteristics | Years of Experience | |||||
|---|---|---|---|---|---|---|
| Total | >15 | 1–5 | 11–15 | 6–10 | ||
| Usefulness in providing medical care | 3.92 (0.83) | 4.00 (0.79) | 3.91 (0.89) | 4.12 (1.13) | 3.78 (0.65) | 0.767 |
| Usefulness in oral medicine practice | 3.99 (0.78) | 4.00 (0.79) | 4.06 (0.76) | 4.00 (1.20) | 3.83 (0.62) | 0.806 |
| Telemedicine can be used to diagnose new cases | 3.13 (1.03) | 3.18 (0.95) | 3.28 (0.99) | 2.88 (1.36) | 2.94 (1.06) | 0.625 |
| Telemedicine and consultation | 4.13 (0.68) | 4.06 (0.66) | 4.16 (0.72) | 4.50 (0.53) | 4.00 (0.69) | 0.365 |
| Telemedicine and patient follow-up | 4.11 (0.80) | 4.18 (0.53) | 4.06 (0.98) | 4.62 (0.52) | 3.89 (0.68) | 0.176 |
| Telemedicine and refilling medication | 4.03 (0.87) | 3.88 (0.99) | 4.06 (0.95) | 4.38 (0.74) | 3.94 (0.64) | 0.588 |
| Telemedicine and reduction in follow-up visits | 4.09 (0.95) | 4.18 (1.01) | 3.97 (1.03) | 4.50 (0.76) | 4.06 (0.80) | 0.542 |
| Telemedicine and patient referral | 3.95 (0.93) | 4.12 (0.93) | 3.94 (1.01) | 4.00 (1.07) | 3.78 (0.73) | 0.760 |
| To facilitate communication and clinical discussion with colleagues | 4.48 (0.62) | 4.47 (0.51) | 4.50 (0.62) | 4.62 (0.52) | 4.39 (0.78) | 0.842 |
| Role in overall cost reduction | 4.15 (0.83) | 4.06 (1.03) | 4.28 (0.89) | 4.38 (0.52) | 3.89 (0.58) | 0.346 |
| To reduce the patient travel cost and time for follow-up visits | 4.47 (0.66) | 4.41 (0.80) | 4.50 (0.62) | 4.75 (0.46) | 4.33 (0.69) | 0.506 |
| Usefulness in education and training | 4.36 (0.71) | 4.35 (0.49) | 4.38 (0.87) | 4.62 (0.52) | 4.22 (0.65) | 0.622 |
| Wiliness to integrate telemedicine with clinical practice | 4.21 (0.76) | 4.35 (0.61) | 4.09 (0.89) | 4.62 (0.52) | 4.11 (0.68) | 0.258 |
Notes: ANOVA test was conducted to compare respondent’s experience level and future implications of telemedicine. p < 0.05 was considered as significant.
Comparison Between Experience Levels with Potential Barriers and Limitations of Telemedicine in the Oral Medicine Practice
| Characteristics | Year of Experience | |||||
|---|---|---|---|---|---|---|
| Total | >15 | 1–5 | 11–15 | 6–10 | ||
| Poor setup for telemedicine at the workplace | 3.65 (0.95) | 3.59 (0.71) | 3.62 (1.01) | 4.12 (0.83) | 3.56 (1.10) | 0.528 |
| Low level of knowledge and training on telemedicine technology among medical staff | 3.61 (0.96) | 2.88 (0.86) | 3.81 (1.00) | 3.88 (0.99) | 3.83 (0.62) | 0.003* |
| Poor resolution of clinical pictures and radiographical images through the telemedicine applications can affect the clinical judgment | 4.13 (0.92) | 3.82 (1.07) | 4.25 (0.88) | 3.88 (0.99) | 4.33 (0.77) | 0.273 |
| Telemedicine is of limited value in clinical diagnosis | 3.28 (1.05) | 2.76 (1.03) | 3.53 (0.88) | 3.25 (1.39) | 3.33 (1.08) | 0.109 |
| Lack of familiarity using telemedicine technology and smart applications among patients | 3.69 (0.88) | 3.47 (0.72) | 3.75 (0.88) | 3.88 (1.25) | 3.72 (0.89) | 0.676 |
| Telemedicine is not a substitute to clinical visit for the new patient | 4.24 (0.84) | 4.06 (0.66) | 4.12 (0.83) | 4.62 (1.06) | 4.44 (0.86) | 0.245 |
| Telemedicine may not be accepted by patients due to cultural reasons | 3.56 (1.07) | 3.24 (1.15) | 3.69 (0.93) | 3.25 (1.49) | 3.78 (1.00) | 0.333 |
| Telemedicine service may not be covered by medical insurance | 3.51 (0.94) | 3.65 (0.70) | 3.25 (0.88) | 3.50 (1.20) | 3.83 (1.04) | 0.173 |
| Telemedicine might not be approved by institute administration | 3.40 (0.89) | 3.24 (0.90) | 3.44 (0.84) | 3.38 (1.51) | 3.50 (0.62) | 0.836 |
| Professional telemedicine practice needs a strong IT infrastructure | 3.97 (0.93) | 3.82 (0.88) | 3.81 (1.00) | 4.75 (0.46) | 4.06 (0.87) | 0.065 |
| The use of telemedicine might jeopardize the patient’s privacy and confidentiality and pose a legal liability | 3.28 (0.92) | 3.29 (0.69) | 3.28 (1.02) | 3.12 (1.36) | 3.33 (0.77) | 0.964 |
| The use of telemedicine might carry cyber risk and data insecurity | 3.65 (0.83) | 3.59 (0.62) | 3.66 (0.97) | 3.38 (1.06) | 3.83 (0.62) | 0.613 |
| Do respondents recommend adopting telemedicine use in the oral medicine specialty | 4.00 (0.90) | 4.06 (0.75) | 3.84 (1.05) | 4.50 (0.76) | 4.00 (0.77) | 0.325 |
Notes: ANOVA was conducted to compare the experience level with the potential barriers and limitations of telemedicine in the oral medicine practice. *p < 0.05 was considered as significant.
Prediction of Future Implications of Telemedicine in Oral Health Practice
| Variable | B | 95% CI | β | |||
|---|---|---|---|---|---|---|
| (Intercept) | 3.88 | 0.18 | 3.53–4.24 | 0.00 | 21.72 | 0.001* |
| C1 No | −0.62 | 0.22 | −1.06–0.18 | −0.28 | −2.84 | 0.006* |
| C2 Yes | 0.14 | 0.14 | −0.13–0.41 | 0.12 | 1.01 | 0.317 |
| C3 Yes | 0.13 | 0.17 | −0.20–0.46 | 0.11 | 0.79 | 0.434 |
| C3 No | −0.03 | 0.14 | −0.31–0.25 | −0.03 | −0.20 | 0.841 |
| C4 No | −0.02 | 0.13 | −0.29–0.25 | −0.02 | −0.15 | 0.881 |
| C6 Yes | −0.28 | 0.15 | −0.59–0.03 | −0.25 | −1.83 | 0.072 |
| R3 Yes | 0.17 | 0.12 | −0.07–0.41 | 0.14 | 1.44 | 0.156 |
| R5 Yes | 0.45 | 0.12 | 0.22–0.69 | 0.41 | 3.83 | 0.001* |
| R5 No | −0.07 | 0.20 | −0.46–0.32 | −0.04 | −0.35 | 0.731 |
| R6 satisfied | 0.21 | 0.13 | −0.05–0.48 | 0.19 | 1.62 | 0.109 |
| R6 dissatisfied | −0.53 | 0.26 | −1.05–0.02 | −0.22 | −2.07 | 0.042* |
Notes: A linear regression analysis was conducted to assess how the factors C1, C2, C3, C4, C6, R3, R5, and R6 significantly predicted future implications of telemedicine (F). *p < 0.05 was considered as significant. C1 = “Was clinic deferred due to the COVID-19 pandemic?”, C2 = “Familiarity with the use of telemedicine?”, C3 = “Does practice setup support the use of telemedicine?”, C4 = “Have the respondent ever utilized any form of telemedicine before the COVID-19 pandemic?”, C6 = “Have the respondent been in communication with patients via telemedicine during the COVID-19 pandemic?”, R3 = “Do the consent of patients was taken before telemedicine session?”, R5 = “Was it convenient to use telemedicine?”, R6 = “Overall, how satisfied were the patients with the telemedicine services?”.
Identification of Potential Barriers and Limitations of Telemedicine in the Oral Health Practice
| Variable | B | 95% CI | β | |||
|---|---|---|---|---|---|---|
| Intercept | 4.05 | 0.17 | 3.70–4.39 | 0.00 | 23.63 | 0.001* |
| C1No | 0.18 | 0.21 | −0.24–0.60 | 0.10 | 0.84 | 0.401 |
| C2Yes | −0.08 | 0.13 | −0.34–0.18 | −0.09 | −0.60 | 0.552 |
| C3Yes | −0.02 | 0.16 | −0.34–0.30 | −0.02 | −0.11 | 0.913 |
| C3No | 0.16 | 0.13 | −0.11–0.43 | 0.18 | 1.20 | 0.234 |
| C4No | −0.25 | 0.13 | −0.50–0.01 | −0.28 | −1.91 | 0.060 |
| C6Yes | −0.19 | 0.15 | −0.48–0.10 | −0.22 | −1.30 | 0.198 |
| R3Yes | 0.02 | 0.11 | −0.21–0.25 | 0.02 | 0.15 | 0.881 |
| R5Yes | −0.32 | 0.11 | −0.55–0.10 | −0.37 | −2.87 | 0.006* |
| R5No | −0.19 | 0.19 | −0.56–0.19 | −0.13 | −1.00 | 0.321 |
| R6 satisfied | 0.03 | 0.13 | −0.22–0.28 | 0.03 | 0.22 | 0.829 |
| R6 dissatisfied | 0.03 | 0.25 | −0.47–0.52 | 0.01 | 0.10 | 0.917 |
Notes: A linear regression analysis was conducted to assess how the factors C1, C2, C3, C4, C6, R3, R5, and R6 significantly predicted F (future implications of telemedicine). *p < 0.05 was considered as significant. C1= “Was clinic deferred due to the COVID-19 pandemic?”, C2= “Are the respondent were familiar with the use of telemedicine?”, C3= “Does practice setup support the use of telemedicine?”, C4 = “Have respondent ever utilized any form of telemedicine before the COVID-19 pandemic?”, C6 = “Have respondent been in communication with patients via telemedicine during the COVID-19 pandemic?”, R3 = “ Do the consent of patients was taken before telemedicine session?”, R5 = “Was it convenient to use telemedicine?”, R6 = “Overall, how satisfied were the patients with the telemedicine services?”.